Pancreatic Cancer clinical trials
Showing 101–150 of 265 active trials. Describe your situation to see which ones you may be eligible for.
- A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
- Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
- At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
- A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
- A Study of DM005 in Patients With Advanced Solid Tumors
- Single Dose Investigator Initiated Pilot Study to Investigate CYTALUX (Pafolacianine) for Intraoperative Detection of Malignant Tissue in Subjects Undergoing Surgical Resection for Cancer.
- AMT-116 in Patients With Advanced Solid Tumors
- AOH1996 for the Treatment of Refractory Solid Tumors
- CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors
- A Study of PARP1 Selective Inhibitor, EIK1004 (IMP1707) in Participants With Advanced Solid Tumors.
- Study of AZD4956 as Monotherapy and in Combination With Anti-Cancer Agents in Participants With Advanced/Metastatic Homologous Recombination Deficient Solid Tumours
- Study of SGN1 in Patients With Advanced Solid Tumor
- A Study of MGC028 in Participants With Advanced Solid Tumors
- A Beta-only IL-2 ImmunoTherapY Study
- A Study of LY4170156 in Participants With Selected Advanced Solid Tumors
- VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
- Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
- A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
- A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
- Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula
- Mutant KRAS -Targeted Long Peptide Vaccine for Patients at High Risk of Developing Pancreatic Cancer
- A Nutrition & Exercise Prehabilitation Intervention on Inflammatory Biomarkers in AI Cancer Patients
- Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue Injury
- Disposable Perfusion Phantom for Accurate DCE (Dynamic Contrast Enhanced)-MRI Measurement of Pancreatic Cancer Therapy Response
- MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial
- DCE-MRI Guided Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer
- Resistance Exercise Combined With Protein Supplementation in People With Pancreatic Cancer: The RE-BUILD Trial
- A Study of Multiparametric Ultrasound Imaging Methods
- Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
- Computed Tomography in Diagnosing Patients With Pancreatic or Hepatobiliary Cancer
- EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope
- The Vanguard Study: Testing a New Way to Screen for Cancer
- Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism
- Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers
- The Cancer of the Pancreas Screening-5 CAPS5)Study
- Characterization of Hyperpolarized Pyruvate MRI Reproducibility
- Intravital Microscopy in Human Solid Tumors
- 64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer
- A Study of Magnetic Resonance Imaging of the Pancreas for Cancer Screening
- Ultra-High Resolution Optical Coherence Tomography in Detecting Micrometer Sized Early Stage Pancreatic Cancer in Participants With Pancreatic Cancer
- A First-in-Human Study of FID-022 in Solid Tumor Patients
- Outcomes of Ablation of Unresectable Pancreatic Cancer Using the NanoKnife Irreversible Electroporation System-
- Artificial Intelligence in Endoscopic Ultrasound
- WATD and Cancer-Related Fatigue: A Study For Patients Undergoing Anti-Cancer Treatment
- Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts
- Cell-Free DNA Chromatin Immunoprecipitation (ChIP) for Diagnosing Cancer
- Use Of Indocyanine Green In Pancreas Surgery
- Determining Individualized Cancer Therapy in Pancreatic Cancer
- Evaluating Obesity-Mediated Mechanisms of Pancreatic Carcinogenesis in Minority Populations
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.